Literature DB >> 16985586

Vitamin d for the management of prostate cancer.

Masood A Khan, Alan W Partin.   

Abstract

Entities:  

Year:  2004        PMID: 16985586      PMCID: PMC1472821     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


× No keyword cloud information.
  13 in total

1.  Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31.

Authors:  K A Moffatt; W U Johannes; T E Hedlund; G J Miller
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

2.  Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)

Authors:  C Gross; T Stamey; S Hancock; D Feldman
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

Review 3.  Vitamin D and prostate cancer.

Authors:  S E Blutt; N L Weigel
Journal:  Proc Soc Exp Biol Med       Date:  1999-06

4.  Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

Authors:  G G Schwartz; B S Hulka
Journal:  Anticancer Res       Date:  1990 Sep-Oct       Impact factor: 2.480

5.  Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1.

Authors:  B J Boyle; X Y Zhao; P Cohen; D Feldman
Journal:  J Urol       Date:  2001-04       Impact factor: 7.450

6.  Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3.

Authors:  J A Eisman; D H Barkla; P J Tutton
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

Review 7.  Vitamin D in the prevention and treatment of prostate cancer.

Authors:  B R Konety; C S Johnson; D L Trump; R H Getzenberg
Journal:  Semin Urol Oncol       Date:  1999-05

8.  Natural history of progression after PSA elevation following radical prostatectomy.

Authors:  C R Pound; A W Partin; M A Eisenberger; D W Chan; J D Pearson; P C Walsh
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

9.  High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma.

Authors:  Tomasz M Beer; Dianne Lemmon; Bruce A Lowe; W David Henner
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

10.  Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.

Authors:  Joshua A Bauer; Todd A Thompson; Dawn R Church; Eric A Ariazi; George Wilding
Journal:  Prostate       Date:  2003-05-15       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.